Kansas PKD Research and Translation Core Center

堪萨斯 PKD 研究与翻译核心中心

• 批准号: 10214612
• 负责人: JAMES P CALVET
• 金额: $ 75.83万
• 依托单位: UNIVERSITY OF KANSAS MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-07-15 至 2025-06-30
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10214612
• 关键词: Autosomal Dominant Polycystic Kidney; Basic Science; Biochemistry; Biocompatible Materials; Biological Markers; Biomedical Research; Cancer Center; Cell model; Cell physiology; Cellular biology; Clinical; Clinical Research; Clinical Trials; Clinical Trials Network; Collaborations; Communities; Cyst; Development; Disease; Drug Targeting; Educational workshop; Effectiveness; Environment; Foundations; Goals; Grant; Growth; Infrastructure; Institutes; Institution; Interdisciplinary Study; Kansas; Kidney; Medical center; Methods; Mission; Pathogenesis; Patient-Focused Outcomes; Patients; Polycystic Kidney Diseases; Reagent; Recording of previous events; Research; Research Methodology; Research Personnel; Research Support; Resource Sharing; Resources; Rodent Model; Series; Services; Site; Technology; Testing; Translations; Universities; base; biomarker discovery; clinical development; drug testing; educational atmosphere; improved; innovation; insight; inter-institutional; meetings; multidisciplinary; new technology; novel therapeutic intervention; novel therapeutics; patient oriented; programs; recruit; summer student; symposium; therapeutic target; tool; translational medicine

Project Summary – Overall The Kansas PKD Research and Translation Core Center (RTCC) is comprised of an Administrative Core and three innovative Biomedical Research Cores: Core 1: Biomarkers, Biomaterials, and Cellular Models; Core 2: Rodent Models & Drug Testing; and Core 3: Clinical Research. The Kansas RTCC also offers an Educational Enrichment Program and an internal Pilot Grant Program in partnership with the KU Cancer Center. The mission of the PKD Center is to promote PKD research by providing both innovative and essential reagents, biomaterials, and service to the national PKD research community for the advancement of our understanding of disease mechanisms, the discovery of biomarkers and therapeutic targets and the development of clinical trials to improve patient outcomes. The Specific Aims of the Kansas PKD RTCC are: Aim 1) To support PKD researchers nationally by developing innovative biomedical research cores. This will be accomplished by developing the expertise, reagents and resources required to bring the best new technologies to PKD research to meet the needs of the greater PKD research community; by leveraging existing institutional shared resources to expand our capability, efficiency, and effectiveness; and by developing tools to support clinical research and establish collaborations both regionally and nationally to develop a multi-institutional ADPKD clinical trials network. Aim 2) To develop a skilled, collaborative, multidisciplinary basic science and clinical PKD research investigator base. This will be accomplished by building on our broad multidisciplinary research base and continuing to recruit new investigators from outside the PKD field by offering an innovative pilot grant program that will attract new investigators to the field, and by providing new investigators, nationally, with research support for core services, new technologies, educational opportunities, and an open and collaborative research environment that will help them succeed. Aim 3) To enhance the PKD research environment with educational programs to support ongoing projects and to develop new research directions. The research environment will be enhanced through a seminar program, Summer Student Enrichment Program, PKD lab meetings, PKD methods workshops, Research Methods and Advanced Technologies Program, professional development seminar series, patient-oriented activities, and by participating in the consortium-wide annual symposium. Aim 4) To develop partnerships regionally and nationally and to build teams to serve as a resource for the greater PKD research community. Inter-institutional partnerships will provide local and national infrastructure support, new research technologies, increased numbers of patients involved in clinical trials, and research collaborators for the development of new research opportunities by attracting investigators from other fields into PKD research from collaborating sites within the PKD Research Consortium and with cooperating institutions nationwide, broadening opportunities beyond what any single institution can provide.

项目摘要-整体